Horizon Kinetics Medical ... (MEDX)

NasdaqGM: MEDX · 실시간 가격 · USD

36.49

+0.71 (1.98%)

종가 기준: Aug 18, 2026, 8:00 PM

1.98% (1D)

데이터가 없습니다

매수호가	25.32
시가총액	n/a
운용자산	17.26M
순자산가치	35.87
베타	0.56
EPS (최근 12개월)	n/a
P/E (최근 12개월)	30.88
발행 주식수	n/a
설정일	Sep 30, 1999

매도호가	45.56
거래량	1,786
평균 거래량 (20일)	2,285
시가	36.26
전일 종가	35.78
당일 변동폭	36.26 - 36.49
52주 변동폭	28.32 - 37.79
편입 종목	n/a
총보수	0.85%

MEDX 정보

The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

자산군 Health

종목코드 MEDX

설정일 Sep 30, 1999

운용사 Horizon Kinetics

웹사이트 펀드 홈페이지

거래소 NasdaqGM

배당 배당수익률 1.12%

배당락일	금액	지급일
Dec 23, 2025	$0.4090	n/a
Dec 24, 2024	$0.5020	n/a
Dec 27, 2023	$1.6420	n/a

전체 배당 이력

뉴스

2개월 전 · Simply Wall St.

When Should You Buy medmix AG (VTX:MEDX)?

While medmix AG ( VTX:MEDX ) might not have the largest market cap around , it saw significant share price movement...

5개월 전 · Zacks

Medical ETF (MEDX) Touches New 52-Week High

MEDX hits a new 52-week high, as strength in patented pharma fuels fresh momentum.

6개월 전 · Simply Wall St.

Owning 41% in medmix AG (VTX:MEDX) means that insiders are heavily invested in the company's future

Key Insights Significant insider control over medmix implies vested interests in company growth 52% of the business is...

8개월 전 · Simply Wall St.

medmix (VTX:MEDX) Could Be Struggling To Allocate Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

8개월 전 · Zacks

Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in

Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding the weight-loss drug boom.

2 페이지 중 1